Consultar información por delegación

 
 
ALAD - XVII Congreso Asociación Latinoamericana de Diabetes 2019

BIBLIOALAD

BiblioALAD

ÚLTIMOS ARTÍCULOS DISPONIBLES

Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Food Preferences and Potential Mechanisms Involved
Mette S. Nielsen, Julie B. Schmidt, Carel W. le Roux, Anders Sjödin
Curr. Obes. Rep. 2019 Sep; 8(3). 292-300. DOI: 10.1007/s13679-019-00354-0

Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity
Uchenna Agbim, Rotonya M. Carr, Octavia Pickett-Blakely, Sam Dagogo-Jack
Curr. Obes. Rep. 2019 Sep; 8(3). 243-254. DOI: 10.1007/s13679-019-00349-x

Extrinsic and Intrinsic Immunometabolism Converge: Perspectives on Future Research and Therapeutic Development for Obesity
Heather L. Caslin, Alyssa H. Hasty
Curr. Obes. Rep. 2019 Sep; 8(3). 210-219. DOI: 10.1007/s13679-019-00344-2

FSP27 and Links to Obesity and Diabetes Mellitus
Shakun Karki
Curr. Obes. Rep. 2019 Sep; 8(3). 255-261. DOI: 10.1007/s13679-019-00343-3

Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery
Jean Debédat, Karine Clément, Judith Aron-Wisnewsky
Curr. Obes. Rep. 2019 Sep; 8(3). 229-242. DOI: 10.1007/s13679-019-00351-3

How Group-Based Interventions Can Improve Services for People with Severe Obesity
Dawn Swancutt, Mark Tarrant, Jonathan Pinkney
Curr. Obes. Rep. 2019 Sep; 8(3). 333-339. DOI: 10.1007/s13679-019-00348-y

Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and Behavioral Factors Affecting Changes in Body Weight, Body Composition, and Cardiometabolic Risk
George A. Bray, Ronald M. Krauss, Frank M. Sacks, Lu Qi
Curr. Obes. Rep. 2019 Sep; 8(3). 262-283. DOI: 10.1007/s13679-019-00353-1

Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
Eric Nolen-Doerr, Mary-Catherine Stockman, Ivania Rizo
Curr. Obes. Rep. 2019 Sep; 8(3). 284-291. DOI: 10.1007/s13679-019-00350-4

Nonalcoholic Fatty Liver Disease and Obesity Treatment
Katherine T. Brunner, Cameron J. Henneberg, Robert M. Wilechansky, Michelle T. Long
Curr. Obes. Rep. 2019 Sep; 8(3). 220-228. DOI: 10.1007/s13679-019-00345-1

Oxytocin and Vasopressin Systems in Obesity and Metabolic Health: Mechanisms and Perspectives
Cherlyn Ding, Faidon Magkos
Curr. Obes. Rep. 2019 Sep; 8(3). 301-316. DOI: 10.1007/s13679-019-00355-z

Severe Obesity in the Pediatric Population: Current Concepts in Clinical Care
Claudia K. Fox, Amy C. Gross, Eric M. Bomberg, Justin R. Ryder, Megan M. Oberle, Carolyn T. Bramante, Aaron S. Kelly
Curr. Obes. Rep. 2019 Sep; 8(3). 201-209. DOI: 10.1007/s13679-019-00347-z

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives
Natalia Vallianou, Theodora Stratigou, Gerasimos Socrates Christodoulatos, Maria Dalamaga
Curr. Obes. Rep. 2019 Sep; 8(3). 317-332. DOI: 10.1007/s13679-019-00352-2

High-density lipoprotein: our elusive friend
Bela F. Asztalos, Katrin Niisuke, Katalin V. Horvath
Curr. Opin. Lipidol. 2019 Aug; 30(4). 314-319. DOI: 10.1097/MOL.0000000000000612

Inflammatory joint diseases and atherosclerosis: time to look beyond the -lipid paradox-
Rachel H. Mackey, Lewis H. Kuller, Larry W. Moreland
Curr. Opin. Lipidol. 2019 Aug; 30(4). 342-349. DOI: 10.1097/MOL.0000000000000620

Inheritance of high and low HDL: mechanisms and management
Andreas Sourlas, Constantine E. Kosmas
Curr. Opin. Lipidol. 2019 Aug; 30(4). 307-313. DOI: 10.1097/MOL.0000000000000610

Intestinal lymphatic vessels and their role in chylomicron absorption and lipid homeostasis
Krista Hokkanen, Annakaisa Tirronen, Seppo Ylä-Herttuala
Curr. Opin. Lipidol. 2019 Jul; 30. . DOI: 10.1097/MOL.0000000000000626

Is hypertriglyceridemia atherogenic?
Fabien Huet, Camille Roubille, Francois Roubille
Curr. Opin. Lipidol. 2019 Aug; 30(4). 291-299. DOI: 10.1097/MOL.0000000000000622

Maximizing the benefits of cholesterol-lowering drugs
Kenneth R. Feingold
Curr. Opin. Lipidol. 2019 Jul; 30. . DOI: 10.1097/MOL.0000000000000631

Monocytes and macrophages in atherogenesis
Jaume Amengual, Tessa J. Barrett
Curr. Opin. Lipidol. 2019 Jul; 30. . DOI: 10.1097/MOL.0000000000000634

Monogenic, polygenic, and oligogenic familial hypercholesterolemia
Hayato Tada, Atsushi Nohara, Masa-aki Kawashiri
Curr. Opin. Lipidol. 2019 Aug; 30(4). 300-306. DOI: 10.1097/QCO.0000000000000563

Neointimal hyperplasia: are fatty acid transport proteins a new therapeutic target?
Umar Rekhi, Julia E. Piche, Linnet Immaraj, Maria Febbraio
Curr. Opin. Lipidol. 2019 Jul; 30. . DOI: 10.1097/MOL.0000000000000627

Non-HDL cholesterol should not generally replace LDL cholesterol in the management of hyperlipidaemia
Handrean Soran, Jan H. Ho, Safwaan Adam, Paul N. Durrington
Curr. Opin. Lipidol. 2019 Aug; 30(4). 263-272. DOI: 10.1097/MOL.0000000000000614

Recent developments in lipodystrophy
Audrey Melvin, Anna Stears, David B. Savage
Curr. Opin. Lipidol. 2019 Aug; 30(4). 284-290. DOI: 10.1097/MOL.0000000000000613

Regulation of calcific vascular and valvular disease by nuclear receptors
Tamer Sallam, Yin Tintut, Linda L. Demer
Curr. Opin. Lipidol. 2019 Jul; 30. . DOI: 10.1097/MOL.0000000000000632

Role of serum amyloid A in atherosclerosis
Preetha Shridas, Lisa R. Tannock
Curr. Opin. Lipidol. 2019 Aug; 30(4). 320-325. DOI: 10.1097/MOL.0000000000000616

The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease
Eftaxia-Konstantina Valanti, Angeliki Chroni, Despina Sanoudou
Curr. Opin. Lipidol. 2019 Aug; 30(4). 326-341. DOI: 10.1097/MOL.0000000000000615

The role of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancer
Pallavi Mukherjee, Arnab Chattopadhyay, Alan M. Fogelman
Curr. Opin. Lipidol. 2019 Jul; 30. . DOI: 10.1097/MOL.0000000000000629

Trained immunity and atherosclerotic cardiovascular disease
Niels P. Riksen
Curr. Opin. Lipidol. 2019 Jul; 30. . DOI: 10.1097/MOL.0000000000000628

REVISTA ALAD V9N1

V9N1